Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Medical College of Wisconsin
Incyte Corporation
Janssen Research & Development, LLC
University of California, Irvine
Hoffmann-La Roche
Incyte Corporation
Providence Health & Services
The Methodist Hospital Research Institute
Gustave Roussy, Cancer Campus, Grand Paris
Celyad Oncology SA